July 4, 2016
English Court to consider Premaitha’s defence on Illumia filed case after hearing scheduled for July 2017
English Court to consider Premaitha’s defence after hearing scheduled for July 2017
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Premaitha Health
March 10, 2016
Premaitha signs distribution agreement with GeNext in Russia
Premaitha signs distribution agreement with GeNext in Russia
February 2, 2016
Premaitha partners with Leeds Teaching Hositals NHS Trust to provide NIPT screening service
Premaitha Health, the developer of IONA test, has partnered with Leeds Teaching Hospitals NHS Trust to provide a private NIPT…
December 3, 2015
Adgenix to distribute Premaitha Health’s prenatal screening test Iona in France
Premaitha Health said Wednesday that Adgenix has already signed up its first laboratory customer for Premaitha in France, with a signed contract for a minimum of three years to supply LaboSud with the Iona test.
November 12, 2015
Study shows IONA test can predict the presence of Down’s, Edward’s, and Patau’s syndrome
Study demonstrates the IONA test can accurately predict the presence of the trisomies 21, 18, and 13. Being user-friendly, cost effective and CE-marked will overcome some of the limitations of existing commercial technologies to facilitate implementation in local laboratories.
October 28, 2015
Premaitha Health: Dr William Denman to join the Board as an Executive Director
Premaitha Health PLC, developer of the IONA test, the first CE-marked non-invasive prenatal screening test (NIPT) confirms that Chief Medical Officer, Dr William Denman, will join the Board of Premaitha as an Executive Director on 1 November 2015.
October 16, 2015
The Wolfson Institute and Premaitha Health: World first in-house antenatal reflex DNA screening
The Wolfson Institute of Preventive Medicine with the assistance of Premaitha Health plc , is launching an in-house antenatal reflex DNA screening service on 19 October 2015.
October 14, 2015
Premaitha: New laboratory to meet demand for IONA test service
Premaitha Health plc, developer of the IONA test, the first CE-marked non-invasive prenatal screening test (NIPT) has expanded its in-house NIPT screening service by opening a dedicated laboratory which triples clinical capacity in response to demand for the IONA test from clinicians.